MCS

The Marcus Corporation NYSE

Communication Services ·Entertainment ·US · marcuscorp.com

$17.58

Mkt Cap $540.9M

52w Low $12.85 66.0% of range 52w High $20.02

50d MA $17.42 200d MA $15.87

P/E (TTM) 42.9x

EV/EBITDA 8.7x

P/B 1.2x

Debt/Equity 0.7x

ROE 2.8%

P/FCF 482.5x

RSI (14) —

ATR (14) —

Beta 0.54

50d MA $17.42

200d MA $15.87

Avg Volume 146.0K

About

The Marcus Corporation, together with its subsidiaries, owns and operates movie theatres, and hotels and resorts in the United States. It operates in two segments, Theatres, and Hotels and Resorts. The Theatres segment operates multiscreen motion picture theatres, as well as Funset Boulevard, a family entertainment center. The Hotels and Resorts segment owns and operates full-service hotels and re…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Apr 30, 2026	BMO	-0.54	-0.51	+5.6%	18.98	-3.2%	-7.2%	-7.4%	—	—	—	—	—
Feb 26, 2026	BMO	0.07	-0.06	-185.7%	15.88	+5.2%	+3.4%	+6.0%	+6.0%	+8.3%	+10.1%	+5.7%	—
Oct 31, 2025	BMO	0.43	0.42	-2.3%	13.23	+3.0%	+8.8%	+10.2%	+10.4%	+16.5%	+14.1%	+18.8%	—
Aug 1, 2025	BMO	0.19	0.23	+21.1%	16.37	+3.7%	-9.2%	-9.7%	-8.9%	-10.0%	-7.8%	-6.2%	—
May 6, 2025	BMO	-0.52	-0.54	-3.8%	16.39	-3.9%	-1.3%	+2.5%	+2.7%	+3.4%	+4.0%	+4.5%	—
Feb 27, 2025	BMO	0.04	0.13	+225.0%	20.87	-2.2%	-11.2%	-12.1%	-15.3%	-17.4%	-18.8%	-20.0%	—
Oct 31, 2024	BMO	0.46	0.73	+58.7%	17.17	+4.8%	+9.9%	+20.1%	+22.9%	+25.0%	+30.4%	+34.8%	—
Aug 1, 2024	BMO	-0.01	-0.17	-2659.1%	12.59	-1.1%	+0.4%	+4.6%	+1.7%	+2.1%	-0.1%	+11.9%	—
May 2, 2024	BMO	-0.37	-0.38	-2.7%	13.11	-1.8%	-8.1%	-9.2%	-14.0%	-14.3%	-14.8%	-20.6%	—
Feb 29, 2024	BMO	-0.17	-0.05	+70.6%	14.79	-4.1%	-0.8%	-3.0%	-1.8%	-2.6%	-3.4%	-5.0%	—
Nov 1, 2023	BMO	0.34	0.31	-8.8%	15.54	-3.0%	-1.5%	-1.5%	+0.2%	-0.6%	-1.7%	-8.9%	—
Aug 2, 2023	BMO	0.29	0.35	+20.7%	15.74	+1.7%	+2.1%	+3.3%	+3.3%	+4.8%	+4.6%	-3.4%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 30	Wedbush	Maintains	Outperform → Outperform	—	$18.98	$18.38	-3.2%	-7.2%	-7.4%	—	—	—
Mar 2	Barrington Research	Maintains	Outperform → Outperform	—	$16.83	$16.73	-0.6%	+0.1%	+2.2%	+3.9%	+4.5%	+3.1%
Jan 26	Barrington Research	Maintains	Outperform → Outperform	—	$15.60	$15.60	+0.0%	-2.6%	-2.4%	-4.6%	-3.4%	-3.3%
Dec 12	Barrington Research	Maintains	Outperform → Outperform	—	$16.01	$16.17	+1.0%	+0.7%	-0.6%	-2.1%	-2.1%	-3.3%
Nov 3	Barrington Research	Maintains	Outperform → Outperform	—	$14.40	$14.50	+0.7%	+1.2%	+1.4%	+7.0%	+4.9%	+4.8%
Oct 31	Barrington Research	Maintains	Outperform → Outperform	—	$13.23	$13.63	+3.0%	+8.8%	+10.2%	+10.4%	+16.5%	+14.1%
Oct 6	Benchmark	Maintains	Buy → Buy	—	$15.35	$15.30	-0.3%	-4.1%	-6.6%	-9.3%	-9.8%	-11.9%
Sep 23	Barrington Research	Maintains	Outperform → Outperform	—	$15.47	$15.50	+0.2%	+0.7%	+1.0%	+0.1%	+1.3%	-0.3%
Aug 4	Barrington Research	Maintains	Outperform → Outperform	—	$14.87	$15.14	+1.8%	-0.5%	+0.3%	-0.9%	+1.5%	-1.7%
May 23	Barrington Research	Maintains	Outperform → Outperform	—	$16.92	$16.59	-2.0%	+0.8%	+10.6%	+10.6%	+9.9%	+9.2%
May 6	Barrington Research	Maintains	Outperform → Outperform	—	$16.39	$15.75	-3.9%	-1.3%	+2.5%	+2.7%	+3.4%	+4.0%
Apr 15	Barrington Research	Maintains	Outperform → Outperform	—	$16.21	$16.26	+0.3%	+0.3%	-1.3%	-0.1%	-1.4%	+0.4%
Apr 11	Benchmark	Maintains	Buy → Buy	—	$15.98	$16.06	+0.5%	+0.1%	+1.4%	+1.8%	+0.1%	+1.4%
Mar 3	Barrington Research	Maintains	Outperform → Outperform	—	$18.34	$18.34	+0.0%	-3.6%	-6.0%	-7.6%	-9.3%	-9.5%
Feb 27	Barrington Research	Maintains	Outperform → Outperform	—	$20.87	$20.41	-2.2%	-11.2%	-12.1%	-15.3%	-17.4%	-18.8%
Jan 30	Benchmark	Maintains	Buy → Buy	—	$20.80	$20.92	+0.6%	-2.0%	-3.3%	-1.2%	-0.7%	+3.2%
Nov 25	Benchmark	Maintains	Buy → Buy	—	$22.03	$22.37	+1.5%	+0.3%	-0.5%	+2.0%	+2.8%	+5.1%
Nov 13	Barrington Research	Maintains	Outperform → Outperform	—	$22.12	$22.21	+0.4%	-0.6%	+1.1%	-1.6%	-2.9%	-1.6%
Nov 4	Barrington Research	Maintains	Outperform → Outperform	—	$20.62	$20.81	+0.9%	+2.3%	+4.1%	+8.6%	+6.6%	+6.0%
Nov 1	Benchmark	Maintains	Buy → Buy	—	$18.87	$19.44	+3.0%	+9.3%	+11.8%	+13.7%	+18.7%	+16.5%
Oct 31	Barrington Research	Maintains	Outperform → Outperform	—	$17.17	$18.00	+4.8%	+9.9%	+20.1%	+22.9%	+25.0%	+30.4%
Oct 2	Benchmark	Maintains	Buy → Buy	—	$15.15	$15.46	+2.0%	+6.2%	+5.1%	+4.6%	+2.0%	+1.2%
Sep 20	Barrington Research	Maintains	Outperform → Outperform	—	$14.80	$14.69	-0.7%	+0.3%	+0.5%	+1.5%	+0.9%	+3.2%
Aug 2	Barrington Research	Maintains	Outperform → Outperform	—	$12.64	$12.48	-1.3%	+4.2%	+1.3%	+1.7%	-0.5%	+2.2%
Jul 29	Benchmark	Maintains	Buy → Buy	—	$12.38	$12.50	+1.0%	+0.8%	+1.6%	+1.7%	+2.1%	+6.4%
Jul 8	B. Riley Securities	Maintains	Buy → Buy	—	$10.93	$11.00	+0.6%	-2.7%	-3.5%	-2.3%	+4.9%	+5.7%
May 6	Barrington Research	Maintains	Outperform → Outperform	—	$11.91	$11.92	+0.1%	-5.4%	-5.6%	-6.2%	-0.1%	-3.0%
Apr 22	Barrington Research	Maintains	Outperform → Outperform	—	$13.21	$13.18	-0.2%	+0.9%	+2.6%	+3.3%	+2.0%	+1.1%
Mar 5	Benchmark	Maintains	Buy → Buy	—	$14.53	$14.49	-0.3%	-0.9%	-1.7%	-0.7%	-1.7%	-1.7%
Mar 1	Barrington Research	Maintains	Outperform → Outperform	—	$14.67	$14.57	-0.7%	-2.2%	-1.0%	-1.8%	-2.7%	-1.6%
Jan 2	B. Riley Securities	Maintains	Buy → Buy	—	$14.58	$14.35	-1.6%	-0.6%	-1.3%	-2.1%	-2.7%	-2.7%
May 9	Barrington Research	Maintains	Outperform → Outperform	—	$15.81	$15.74	-0.4%	-0.2%	+0.6%	+0.9%	+0.1%	+1.7%
Apr 10	B. Riley Securities	Maintains	Buy → Buy	—	$16.42	$17.00	+3.5%	+7.7%	+9.2%	+8.6%	+8.1%	+6.8%
Mar 14	Barrington Research	Maintains	Outperform → Outperform	—	$15.27	$15.47	+1.3%	+1.1%	-1.6%	-1.8%	-4.6%	-3.1%
Mar 6	Benchmark	Maintains	Buy → Buy	—	$16.00	$16.03	+0.2%	-0.3%	-0.1%	-2.1%	-3.4%	-3.8%
Dec 5	B. Riley Securities	Maintains	Buy → Buy	—	$16.33	$16.69	+2.2%	+2.4%	+0.4%	-1.9%	-1.4%	-3.7%
Oct 7	Benchmark	Maintains	Buy → Buy	—	$14.27	$14.11	-1.1%	-0.7%	-1.5%	-1.1%	-1.3%	+1.4%
Jun 21	B. Riley Securities	Maintains	Buy → Buy	—	$14.28	$14.52	+1.7%	+1.3%	+1.8%	+2.4%	+3.0%	+4.4%
Nov 24	JP Morgan	Maintains	Neutral → Neutral	—	$19.17	$18.84	-1.7%	-0.8%	-6.6%	-7.2%	-8.9%	-13.2%
Nov 25	Barrington Research	Downgrade	Outperform → Perform	—	$12.58	$12.58	+0.0%	+0.1%	-0.6%	-6.7%	-4.0%	+2.6%
Nov 10	Barrington Research	Upgrade	Market Perform → Outperform	—	$10.62	$11.15	+5.0%	-2.0%	-5.2%	-10.1%	-5.4%	-1.9%
Oct 26	Barrington Research	Downgrade	Outperform → Market Perform	—	$8.33	$7.98	-4.2%	-2.8%	-6.1%	-10.3%	-9.7%	-12.0%
Oct 26	Barrington Research	Downgrade	Outperform → Perform	—	$8.33	$7.98	-4.2%	-2.8%	-6.1%	-10.3%	-9.7%	-12.0%
Jul 6	B. Riley FBR	Upgrade	Neutral → Buy	—	$13.24	$15.27	+15.3%	+10.3%	+4.0%	+9.1%	+10.9%	+13.1%
Jul 6	B. Riley Securities	Upgrade	Neutral → Buy	—	$13.24	$15.27	+15.3%	+10.3%	+4.0%	+9.1%	+10.9%	+13.1%
May 6	B. Riley Securities	Maintains	Neutral → Neutral	—	$12.64	$12.52	-0.9%	-5.4%	-5.1%	+0.6%	-5.6%	-9.7%
May 6	B. Riley FBR	Maintains	Neutral → Neutral	—	$12.64	$12.52	-0.9%	-5.4%	-5.1%	+0.6%	-5.6%	-9.7%
Apr 1	B. Riley Securities	Maintains	Neutral → Neutral	—	$12.32	$11.64	-5.5%	-6.4%	-16.2%	-20.8%	-11.0%	-6.5%
Apr 1	B. Riley FBR	Maintains	Neutral → Neutral	—	$12.32	$11.64	-5.5%	-6.4%	-16.2%	-20.8%	-11.0%	-6.5%
Mar 23	Benchmark	Downgrade	Buy → Hold	—	$10.71	$10.22	-4.6%	-0.7%	+9.7%	+14.0%	+28.1%	+17.0%

Recent Filings

8-K · 5.02 !!! Very High

The Marcus Corporation -- 8-K 5.02: Executive Change

Marcus Theatres President Gramz is retiring effective March 31, 2026, signaling potential leadership transition and strategic direction changes for The Marcus Corporation's theater operations.

Apr 30

8-K

The Marcus Corporation -- 8-K Filing

Marcus Corporation's theater and hotel divisions both exceeded industry performance in Q4, driven by box office pricing strategies and a strong film slate, positioning the company well for continued momentum.

Feb 26

Data updated apr 26, 2026 11:33am · Source: massive.com